Sign up now to have the right to view
10 tenders for free.
Contract Details
| Title |
Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Portugal
|
|---|---|
| Country | |
| Language | English |
| Organization | |
| Published Date | 24.03.2024 |
| Awarded Date | 17.07.2018 |
| Overview | Contract Award's Details : Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Instituto Português De Oncologia Do Porto Francisco Gentil, E. P. E. Country: Portugal Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Contract awarded for Acquisition of exclusive medicines - obinutuzumab, t-dm1 (trastuzumab emtansin), alectinib and pertuzumab Date of conclusion of the contract: 12-07-2018 Contract price: 146. 652,10 € Deadline: 20 days Place of execution - Country, District, Municipality: Portugal port harbor Portugal Contract value : 146,652.00 EUR Contractors : ROCHE FARMACEUTICA QUIMICA, LDA. See in details 18/07/2018 07/08/2018 11214124 18/07/2018 Instituto Português De Oncologia Do Porto Francisco Gentil, E. P. E. Country: Portugal Address : Portugal Portugal Contract Awards Portugal See in details 07/08/2018 146,652.00 EUR |
| NAICS |
-
|
| CPVS | |
| UNSPSC |
-
|
| Regions | |
| Sectors | |
| Contractor | |
| Contract Value |
146,652.00 EUR
|
URL |
| Share |
Portugal
| Title |
|---|
|
Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Portugal
|
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 24.03.2024 |
| Awarded Date |
| 17.07.2018 |
| Overview |
| Contract Award's Details : Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Instituto Português De Oncologia Do Porto Francisco Gentil, E. P. E. Country: Portugal Acquisition Of Exclusive Medicines - Obinutuzumab, T-dm1 (trastuzumab Emtansin), Alectinib And Pertuzumab Contract awarded for Acquisition of exclusive medicines - obinutuzumab, t-dm1 (trastuzumab emtansin), alectinib and pertuzumab Date of conclusion of the contract: 12-07-2018 Contract price: 146. 652,10 € Deadline: 20 days Place of execution - Country, District, Municipality: Portugal port harbor Portugal Contract value : 146,652.00 EUR Contractors : ROCHE FARMACEUTICA QUIMICA, LDA. See in details 18/07/2018 07/08/2018 11214124 18/07/2018 Instituto Português De Oncologia Do Porto Francisco Gentil, E. P. E. Country: Portugal Address : Portugal Portugal Contract Awards Portugal See in details 07/08/2018 146,652.00 EUR |
| NAICS |
| - |
| CPVS |
| Port |
| UNSPSC |
| - |
| Regions |
| Europe Southern Europe Western Europe |
| Sectors |
| Healthcare and Medicine Automobiles and Auto Parts Supply Printing and Publishing Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables |
| Contractor |
| Contract Value |
|
146,652.00 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts